论文部分内容阅读
目的观察左卡尼汀联合蔗糖铁治疗尿毒症血液透析患者贫血的疗效。方法将48例维持性血液透析尿毒症合并贫血患者随机分成两组,治疗组24例,对照组24例。患者在给予常规纠正贫血治疗基础上,治疗组加用左卡尼汀联合蔗糖铁治疗12周。对照组口服琥珀酸亚铁治疗12周,疗程前后均检测两组患者的血红蛋白、红细胞压积、血清铁蛋白。结果治疗组治疗后各项观察指标明显高于对照组(P<0.05)。结论左旋卡尼汀联合蔗糖铁治疗血液透析患者的贫血具有较好疗效。
Objective To observe the curative effect of levocarnitine and sucrose iron on anemia in hemodialysis patients with uremia. Methods 48 patients with maintenance hemodialysis uremia with anemia were randomly divided into two groups, 24 cases in the treatment group and 24 cases in the control group. Patients in the treatment of conventional correction of anemia based on the treatment group plus levocarnitine plus iron sucrose treatment for 12 weeks. Control group oral ferrous succinate treatment for 12 weeks before and after treatment were detected in two groups of patients with hemoglobin, hematocrit, serum ferritin. Results After treatment, the observation group was significantly higher than the control group (P <0.05). Conclusion L-carnitine combined with sucrose iron treatment of hemodialysis patients with anemia has a good effect.